Thai FDA approves emergency use of AstraZeneca COVID-19 vaccine
0 Comment(s)
Print
E-mail Xinhua, January 21, 2021
BANGKOK, Jan. 21 (Xinhua) -- Thailand's Food and Drug Administration (FDA) has approved the registration for emergency use of COVID-19 vaccine developed by AstraZeneca, with the first shipment of 50,000 doses scheduled to arrive next month, a senior official confirmed Thursday.
The first 50,000 doses, produced by AstraZeneca in Italy, will be followed by another 150,000 doses in March and April, according to FDA Secretary General Paisal Dunkhum.
The imported AstraZeneca vaccine is yet to be certified for quality and health safety by the Department of Medical Sciences before use, Paisal said.
For the production of the AstraZeneca vaccine in Thailand by Siam Bioscience Co., the FDA chief said vaccines produced locally will not be available for use until May. Enditem
Go to Forum >>0 Comment(s)